日本ウォーターズ(米国本社 Waters Corporation)  Official site

  • SEMINAR_EVENT

Waters' latest technology to solve the analytical challenges of diversifying modalities [CPHI Japan 2026 (International Pharmaceutical Development Exhibition)] exhibition booth.

日本ウォーターズ(米国本社 Waters Corporation) 

日本ウォーターズ(米国本社 Waters Corporation) 

CPHI Japan 2026 (International Pharmaceutical Development Exhibition), please visit the Waters booth. ■ HRMS that anyone can use. BioAccord LC/MS system accelerating upstream development Benefits of introducing LC-MS into biopharmaceutical process development: - Monitor component variations in culture media and seamlessly optimize culture conditions - Achieve optimal clone selection through early evaluation of quality characteristics in upstream processes *We will conduct a waters_connect software demonstration. ■ Capturing the "true form" of polymers and nanoparticles DAWN Multi-Angle Light Scattering Detector (MALS) Benefits in the characterization of increasingly complex modalities: - Measure the absolute molecular weight of biomacromolecules non-destructively without using standard substances - Evaluate the physical properties of all modalities in detail over a wide dynamic range - Calculate the Full/Empty ratio of AAV and the DAR of ADC using LC-MALS

  • Date and time Tuesday, Apr 21, 2026 ~ Thursday, Apr 23, 2026
    10:00 AM ~ 05:00 PM
  • Capital Tokyo Big Sight East Hall, Equipment and Devices Zone, 3G-31
  • Entry fee Free Entry requires prior registration. Please register in advance.

Related catalog

BioAccord System with ACQUITY Premier for Routine Analysis of Biopharmaceuticals

PRODUCT

MALS Detector DAWN Series Catalog

PRODUCT